First Time Loading...

Amneal Pharmaceuticals Inc
NYSE:AMRX

Watchlist Manager
Amneal Pharmaceuticals Inc Logo
Amneal Pharmaceuticals Inc
NYSE:AMRX
Watchlist
Price: 6.06 USD -0.98% Market Closed
Updated: Mar 29, 2024

Relative Value

The Relative Value of one AMRX stock under the Base Case scenario is 17.89 USD. Compared to the current market price of 6.06 USD, Amneal Pharmaceuticals Inc is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMRX Relative Value
Base Case
17.89 USD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
76
Median 3Y
0.6
Median 5Y
0.7
Industry
2.4
Forward
0.7
vs History
vs Industry
1
Median 3Y
-4.7
Median 5Y
-4.7
Industry
22.3
Forward
10.2
vs History
58
vs Industry
43
Median 3Y
5.7
Median 5Y
5.8
Industry
16.8
vs History
7
vs Industry
11
Median 3Y
6.4
Median 5Y
-1.1
Industry
20.5
vs History
1
vs Industry
0
Median 3Y
3.9
Median 5Y
4.1
Industry
2
vs History
60
vs Industry
55
Median 3Y
1.8
Median 5Y
2
Industry
2.6
Forward
1.7
vs History
55
vs Industry
39
Median 3Y
4.9
Median 5Y
5.4
Industry
5.1
vs History
63
vs Industry
36
Median 3Y
8.7
Median 5Y
9.8
Industry
13.2
Forward
7.3
vs History
77
vs Industry
27
Median 3Y
18.5
Median 5Y
21.3
Industry
16.1
Forward
8.2
vs History
76
vs Industry
30
Median 3Y
17.5
Median 5Y
17.5
Industry
15
vs History
66
vs Industry
22
Median 3Y
20.9
Median 5Y
20.9
Industry
15.8
vs History
15
vs Industry
49
Median 3Y
1.3
Median 5Y
1.2
Industry
2

Multiples Across Competitors

AMRX Competitors Multiples
Amneal Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amneal Pharmaceuticals Inc
NYSE:AMRX
1.9B USD 0.8 -22.2 8.8 16.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
738.6B USD 21.6 140.9 63.6 73
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 47 34.3 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
380.8B USD 4.5 10.8 12.2 15.9
US
Merck & Co Inc
NYSE:MRK
334B USD 5.6 915.2 45.4 88.7
UK
AstraZeneca PLC
LSE:AZN
165.5B GBP 4.6 35.1 138.9 222.8
CH
Roche Holding AG
SIX:ROG
183.1B CHF 3.1 15.9 8.8 10.4
CH
Novartis AG
SIX:NOVN
178.6B CHF 4.2 13.3 9.8 16.1
US
Pfizer Inc
NYSE:PFE
156.7B USD 2.7 73.9 11.1 16.6
P/E Multiple
Earnings Growth
US
Amneal Pharmaceuticals Inc
NYSE:AMRX
Average P/E: 156.5
Negative Multiple: -22.2
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
140.9
340%
DK
Novo Nordisk A/S
CSE:NOVO B
47
77%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
10.8
-21%
US
Merck & Co Inc
NYSE:MRK
915.2
7 433%
UK
AstraZeneca PLC
LSE:AZN
35.1
172%
CH
Roche Holding AG
SIX:ROG
15.9
27%
CH
Novartis AG
SIX:NOVN
13.3
18%
US
Pfizer Inc
NYSE:PFE
73.9
679%

See Also

Discover More